Corporate action official notices
iShares (DE) - Dividend Declaration Pay Date 15 May 2024
DE0006289465
Final/Interim Distribution in respect of current financial year Announcement Date: 25 April 2024 Ex Date: 15 May 2024 Record Date: - Payment Date: 15 May 2024
The Swatch Group AG - Ausschüttungen / Indikative (vorläufige) Meldung
CH0012255144, CH0012255151
Dividendenausschüttung auf dem Aktienkapital von CHF 117'719’775.00 • CHF 1.30 pro Namenaktie = Total CHF 151'995’350.00 • CHF 6.50 pro Inhaberaktie = Total CHF 188'084'000.00 CHF 340'079'350.00 Ex-Date: 13.05.2024 Record-Date: 14.05.2024 Payment-Date: 15.05.2024
Short Mini Future auf Adidas AG
CH1332107585
Short Mini Future auf Geberit AG
CH1341864549
Short Mini Future auf Holcim AG
CH1341864473
Vattenfall 24
XS0191154961
Leonteq Securities AG: Anpassung von Barrier Reverse Convertibles auf Petrobras ADR
CH1171797637, CH1290292221
Basiswert: PETROLEO BRASILEIRO-SPON ADR PETROLEO BRASILEIRO-SPON ADR hat eine Sonderdividende von USD 0.6811062 pro Aktie ausgeschüttet. Die Bedingungen dieser Emission wurden gemäss Anhang angepasst.
Leonteq Securities AG: Aufhebung der Zulassung zum Handel (Sponsored Segment)
CH1260041939
Emittentin: ObsEva S.A., Chemin des Aulx 12 Genf, 1228 Switzerland ISIN: CH1260041939 Titel: Aufhebung der Zulassung zum Handeln (Sponsored Segment) Beschrieb: Delisting am primären Handelsplatz Kontakt: David, Haab, (Leonteq Securities AG) Europaallee 39, 8004 Zürich Telefon: +41 79 622 32 47 E-Mail: david.haab@leonteq.com Datum des Inkrafttretens der Änderung:03.05.2024 Datum der Veröffentlichung: 02.05.2024 Für die folgenden Instrumente wird die Zulassung zum Handeln aufgehoben (Sponsored Shares): SPONSORED SHARES: ISIN: CH1260041939 Name: ObsEva S.A Share Class: Inhaberaktie Nominal Value: 0.0769 CHF Grund: Aufhebung der Zulassung zum Handeln (Sponsored Segment) Letzter Handelstag: 03 Mai 2024 Datum der Veröffentlichung: 02 Mai 2024 Leonteq Securities AG Retail Flow Business (RFB) +41 58 800 11 99 david.haab@leonteq.com flowtrading@leonteq.com
Listing of Exchange Traded Product on Solactive® Longevity NTR Index (VITAC)
CH1292088973
Issuer: Leonteq Securities AG, Zurich, Switzerland Security description/name: Exchange Traded Product on Solactive® Longevity NTR Index Swiss Security number: 129208897 ISIN: CH1292088973 BX Symbol: VITAC Issue Size: 1'000'000 Products Currency: CHF Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 21 September 2023 and the performance of the Product is linked to the Solactive® Longevity NTR Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It is categorized as an Exchange Traded Product and will be listed on the respective segment of BX Swiss. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 03.05.2024. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland
Listing of Exchange Traded Product on Solactive® Longevity NTR Index (VITAD)
CH1292088981
Issuer: Leonteq Securities AG, Zurich, Switzerland Security description/name: Exchange Traded Product on Solactive® Longevity NTR Index Swiss Security number: 129208898 ISIN: CH1292088981 BX Symbol: VITAD Issue Size: 1'000'000 Products Currency: USD Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 21 September 2023 and the performance of the Product is linked to the Solactive® Longevity NTR Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It is categorized as an Exchange Traded Product and will be listed on the respective segment of BX Swiss. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 03.05.2024. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland
Strike/Barrier Adjustments SG - 03.05.2024
The following strike/barrier adjustments were made:
Tracker Certificate on The Graph
CH1292089062
Tracker Certificate on The Graph
CH1292089070
Tracker Certificate on The Graph
CH1292089088
iShares I - Dividend Declaration Pay Date 15 May 2024
IE00BVDPJP67
Interim Distribution in respect of current financial year Announcement Date: April 24, 2024 Ex Date: May 2, 2024 Record Date: May 3, 2024 Payment Date: May 15 2024
Leonteq Securities AG: Anpassung von Barrier Reverse Convertibles auf Hermès
CH1318753105, CH1318753147
Basiswert: HERMES INTERNATIONAL HERMES INTERNATIONAL hat eine Sonderdividende von EUR 10.0 pro Aktie ausgeschüttet. Die Bedingungen dieser Emission wurden gemäss Anhang angepasst.
Leonteq Securities AG: Early Redemptions
CH1171801082
The following instrument is subject to an early redemption: ISIN CH1171801082 Reason for the redemption: Issuer call Effective from: 2 May 2024 Publication as of: 3 May 2024
Listing of Exchange Traded Product on Adaptivv Downside Control Carbon
CH1336237073
Issuer: Leonteq Securities AG, Guernsey Branch, St Peter Port, Guernsey Security description/name: Exchange Traded Product on Adaptivv Downside Control Carbon Emissions Index Swiss Security number: 133623707 ISIN: CH1336237073 BX Symbol: ADCO2 Issue Size: 2'000'000 Products Currency: USD Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 21 September 2023 and the performance of the Product is linked to the Adaptivv Downside Control Carbon Emissions Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It is categorized as an Exchange Traded Product and will be listed on the respective segment of BX Swiss. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 02.05.2024. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland
Listing of Exchange Traded Product on Adaptivv Downside Control Uranium Index
CH1336237065
Issuer: Leonteq Securities AG, Guernsey Branch, St Peter Port, Guernsey Security description/name: Exchange Traded Product on Adaptivv Downside Control Uranium Index Swiss Security number: 133623706 ISIN: CH1336237065 BX Symbol: ADUI Issue Size: 2'000'000 Products Currency: USD Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 21 September 2023 and the performance of the Product is linked to the Adaptivv Downside Control Uranium Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It is categorized as an Exchange Traded Product and will be listed on the respective segment of BX Swiss. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 02.05.2024. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland
Strike/Barrier Adjustments SG - 02.05.2024
The following strike/barrier adjustments were made:
1.73% ZKB Certificate of Deposit 2023 - 2024
CH0589645131
7.00% p.a. Barrier Reverse Convertible on Sika
CH1261322452
9.00% p.a. Barrier Reverse Convertible on Generali
CH1277659301
Carrefour 24
XS1401331753
Short Mini Future auf ALPHABET INC-CL A
CH1332107841